Skip to content

CHELSEA THERAPEUTICS INTERNATIONAL, LTD.: filings

Every CHELSEA THERAPEUTICS INTERNATIONAL, LTD. annual and quarterly report in the SEC record with the published financial measures it tagged, 12 filings, each linked to its SEC index.

Filing record ends 2014-05-09

The latest filing in this captured record is a 10-Q filed 2014-05-09. No later filing is in the SEC companyfacts record captured on 2026-09-23. CHELSEA THERAPEUTICS INTERNATIONAL, LTD. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2014-05-09fiscal Q1 201426680001144204-14-029111
10-K2014-03-11fiscal FY 2013251040001144204-14-014836
10-Q2013-11-05fiscal Q3 201325770001144204-13-058837
10-Q2013-08-06fiscal Q2 201325770001144204-13-043270
10-Q2013-05-01fiscal Q1 201325650001144204-13-025705
10-K2013-03-07fiscal FY 2012291130001144204-13-013609
10-Q2012-11-07fiscal Q3 201226800001144204-12-060045
10-Q2012-08-07fiscal Q2 201226810001144204-12-043342
10-Q2012-05-01fiscal Q1 201225610001193125-12-200720
10-K2012-03-07fiscal FY 201126910001193125-12-101178
10-Q2011-11-02fiscal Q3 201125740001193125-11-292949
10-Q2011-07-27fiscal Q2 201125740001193125-11-198939

Inspect the source

Entity
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. / CIK 0001333763
Captured
SEC response SHA-256
354bb9243ece9eacb7fe265090cbbf659edca4a013cc87523793af082dfdb51c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001333763.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))